StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$44.84−1.52 (-3.28%)

Close on Nov 17, 2026Market cap $3.20BP/E –Yield –

Pulse Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Pulse Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$61.10M. For fiscal 2025 it was -$54.12M. The highest annual figure on record is -$3.32M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$54.12M–
FY2024Dec 31, 2024-$36.34M–
FY2023Dec 31, 2023-$33.04M–
FY2022Dec 31, 2022-$47.01M–
FY2021Dec 31, 2021-$54.10M–
FY2020Dec 31, 2020-$35.37M–
FY2019Dec 31, 2019-$34.19M–
FY2018Dec 31, 2018-$23.90M–
FY2017Dec 31, 2017-$11.09M–
FY2016Dec 31, 2016-$8.05M–
FY2015Dec 31, 2015-$3.32M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$18.71M–
Q1 FY2026Mar 31, 2026-$14.60M–
Q4 FY2025Dec 31, 2025-$14.76M–
Q3 FY2025Sep 30, 2025-$13.04M–
Q2 FY2025Jun 30, 2025-$12.81M–
Q1 FY2025Mar 31, 2025-$13.52M–
Q4 FY2024Dec 31, 2024-$9.14M–
Q3 FY2024Sep 30, 2024-$9.02M–
Q2 FY2024Jun 30, 2024-$8.40M–
Q1 FY2024Mar 31, 2024-$9.78M–
Q4 FY2023Dec 31, 2023-$6.78M–
Q3 FY2023Sep 30, 2023-$10.49M–
Q2 FY2023Jun 30, 2023-$9.20M–
Q1 FY2023Mar 31, 2023-$6.57M–
Q4 FY2022Dec 31, 2022-$7.97M–
Q3 FY2022Sep 30, 2022-$10.63M–
Q2 FY2022Jun 30, 2022-$12.82M–
Q1 FY2022Mar 31, 2022-$15.59M–
Q4 FY2021Dec 31, 2021-$12.69M–
Q3 FY2021Sep 30, 2021-$13.35M–
Q2 FY2021Jun 30, 2021-$16.37M–
Q1 FY2021Mar 31, 2021-$11.69M–
Q4 FY2020Dec 31, 2020-$9.26M–
Q3 FY2020Sep 30, 2020-$8.55M–
Q2 FY2020Jun 30, 2020-$7.94M–
Q1 FY2020Mar 31, 2020-$9.62M–
Q4 FY2019Dec 31, 2019-$9.20M–
Q3 FY2019Sep 30, 2019-$7.97M–
Q2 FY2019Jun 30, 2019-$9.69M–
Q1 FY2019Mar 31, 2019-$7.33M–
Q4 FY2018Dec 31, 2018-$6.31M–
Q3 FY2018Sep 30, 2018-$6.85M–
Q2 FY2018Jun 30, 2018-$5.72M–
Q1 FY2018Mar 31, 2018-$5.02M–
Q4 FY2017Dec 31, 2017-$3.96M–
Q3 FY2017Sep 30, 2017-$3.42M–
Q2 FY2017Jun 30, 2017-$1.21M–
Q1 FY2017Mar 31, 2017-$2.50M–
Q4 FY2016Dec 31, 2016-$2.32M–
Q3 FY2016Sep 30, 2016-$1.98M–

More Pulse Biosciences figures

See a number that looks wrong?